Genmab reported DKK1.22B in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Agios Pharmaceuticals USD 24.22M 8.08M Jun/2026
Almirall EUR 196.15M 20.22M Jun/2026
Amarin USD 126.83M 477K Dec/2025
Amgen USD 10.35B 126M Sep/2026
argenx SE USD 2.01B 352.94M Jun/2026
AstraZeneca USD 18.87B 11M Sep/2026
Bayer EUR 17.41B 1.29B Sep/2026
BioMarin Pharmaceutical USD 1.08B 15.31M Sep/2026
Demant DKK 5.93B 426M Jun/2026
Exelixis USD 328.47M 6.25M Sep/2026
Fresenius Medical Care EUR 3.45B 15.38M Sep/2026
Genmab DKK 1.22B 192M Jun/2026
GlaxoSmithKline GBP 8.52B 451M Sep/2026
GN Store Nord DKK 3.46B 464M Sep/2026
GRIFOLS EUR 1.08B 110M Sep/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Insmed USD 259.27M 43.94M Sep/2026
Lakefront Biotherapeutics EUR 147.02M 2.44M Sep/2026
Lonza CHF 1.78B 55M Dec/2025
Merck EUR 4.89B 66M Sep/2026
Novartis USD 9.96B 109M Sep/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 326M 166M Sep/2026
UCB EUR 1.97B 54M Dec/2025